Stocks
ProQR Therapeutics N.V.PRQR
NASDAQHealthcareBiotechnology$1.59
A clinical-stage biotechnology company developing RNA-based therapies for rare genetic diseases. Its pipeline centers on antisense and RNA-editing technologies designed to correct mutations at the RNA level, with programs targeting inherited retinal and other rare disorders. Investors closely follow...
52W Range: $1.07 – $3.10
Congressional Interest in ProQR Therapeutics N.V. (PRQR)
3 members of Congress have disclosed 4 trades in ProQR Therapeutics N.V. (PRQR), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
4
Unique Politicians
3
Buys
4
Sells
0
Who in Congress Is Trading PRQR?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-12-21 | John Rutherford | buy | $1K – $15K |
| 2017-10-02 | John Rutherford | buy | $1K – $15K |